Drugs Made In America Acquisition II Corp. Unit
NASDAQ:DMIIU · NASDAQ Global Select
+$0.02 today
Vol 0.00M · Avg 0.00M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Saleem Elmasri | CFO & Principal Accounting Officer | — | — | 39 | — | — |
Roger Bendelac | Chief Executive Officer | — | — | 69 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
General American Investors Company, Inc.
NYSE:GAM
$1.53B
Nuveen Churchill Direct Lending Corp.
NYSE:NCDL
$601.29M
Gladstone Investment Corporation
NASDAQ:GAIN
$588.39M
MSC Income Fund, Inc.
NYSE:MSIF
$534.85M
NewtekOne, Inc.
NASDAQ:NEWT
$393.09M
Eagle Point Income Company Inc.
NYSE:EIC
$236.33M
OFS Credit Company, Inc.
NASDAQ:OCCI
$74.02M
Who manages DMIIU?
Drugs Made In America Acquisition II Corp. Unit (DMIIU) lists 2 active executives. The top listed executive is Saleem Elmasri, CFO & Principal Accounting Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.